The invention relates to small chemical compounds for reating Malaria.
Scientists associated with the University of Bonn have identified a set of small…
Beside cardiovascular diseases, malignant tumours take
the second place in cause of human death. Neoplastic
…
Inhibitors for use in human therapy Invention
The invention provides a new class of nucleosides
…
Scientists at the University of Duesseldorf and the University of Erlangen have developed new small molecules which can be used for the treatment of diseases…
Invention
Scientists at the University of Münster, Germany, have isolated and characterized a novel substance class from Cocoa. CocoaHeal is capable of…
Professor Ritter and his co-workers from the Division of Virology, University Hospital of the RWTH Aachen, created a new recombinant Epstein-Barr Virus (EBV)
which has lost the ability to enter the state of latent persistency after infecting host cells. The mutant virus only causes a self-limited infection and is unable to immortalize B-lymphocytes following Infection. Having lost the oncogenic potential of wild type EBV it fulfils the prerequisite for a live vaccine.
The inventors generated a mutant virus allowing expression of lytic genes, but preventing the expression of EBV encoded genes essential for the establishment of
viral latency. Mutant virus infected B-lymphocytes died after the productive phase….
Scientists at the RWTH Aachen have identified new
peptides which can be used for the prevention of
atherosclerosis or in the treatment of…
A novel fermentation method for fed-batch operating
conditions, based on microtiterplates (MTPs) was developed at the Dept. of Biochemical Engineering, RWTH…
The therapeutic use of dendritic cells in vaccination
therapy requires prior activation of these immune
…
Scientists at the University of Cologne have developed a new inducible expression system, which is easy to use, reliable and very fast. The System is based on…
Scientists at the University of Cologne, Germany, have linked successfully a trans-membrane ATPase to the hereditary parkinsonism Kufor Rakeb syndrome PARK9….
The Chair of Biochemical Engineering at RWTH Aachen
University developed a novel fermentation method for fedbatch operating conditions, based on…
Scientists at the University of Bonn have identified new small molecules which can be used for the treatment of diseases characterized by alterations of…
A novel ex vivo method for immediate early diagnosis and prognosis of proliferative diabetic retinopathy (DRP) is provided with DRPevader.
DRPevader is based…
Scientists at the University of Bonn, Germany, have identified the main target antigen for the atypical antineutrophil
cytoplasmic antibodies pANCA in…
These delivery particles are characterised by an innovative architecture with a dendritic core and a multilayer shell. Due to their uni-molecular structure the…
Feedback
